Marksans Pharma Limited Other Current Liabilities

Marksans Pharma Limited (MARKSANS.BO) currently reports a other current liabilities of $1.3B as of September 2026. That compares with $750M in the prior-year period — up 70.7% year over year. Use the charts on this page to explore Marksans Pharma Limited's other current liabilities history and peer comparisons.

Marksans Pharma Limited's other current liabilities increased from $750M to $1.3B — a 70.7% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Marksans Pharma Limited reported $1.3B in other current liabilities as of September 2026. That compares with $750M in the prior-year period — up 70.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $1.3B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Marksans Pharma Limited, and consider following MARKSANS.BO for alerts when major investors trade the stock.